In an independent cohort, microarray analysis revealed no hepatic gene expression changes related to NrG4 and its receptor family ErbB between biopsied obese patients with NAFL, NASH and normal livers. Here, EGFR is linked to metabolic dysfunction-associated steatohepatitis.